Instead of charging doctors for its valuable productivity tools, Doximity offers them for free to maximize user engagement. This creates a highly concentrated, valuable audience of physicians, which is then monetized through targeted advertising from pharmaceutical companies, its primary revenue source.

The traditional B2B marketing mix of SEO, paid search, and content is no longer sufficient. Modern growth relies on activating word-of-mouth through a superior product, leveraging founder social presence for authenticity, and investing heavily in the creator economy (especially YouTube) to reach engaged B2B audiences.

The pharmaceutical industry is often misunderstood because it communicates through faceless corporate entities. It could learn from tech's "go direct" strategy, where leaders tell compelling stories. Highlighting the scientists and patient journeys behind breakthroughs could dramatically improve public perception and appreciation.

Instead of treating all channels equally, identify which customer segments (e.g., brand advertisers) are best served by which channels (e.g., TV screens). Shifting demand accordingly can unlock massive growth by optimizing the entire portfolio and increasing customer ROI.

The real economic value of generative video lies in advertising, not filmmaking. Unlike movies with finite consumption, there is unlimited demand for personalized, diverse ad content. This makes advertising a perfect fit for the technology's scalable content creation capabilities.

Doximity's product development is 'unapologetically' focused on increasing doctor productivity and saving them time. This user-centric approach builds deep engagement and trust, creating the highly valuable physician audience that forms the foundation of its advertising-based business model.

Unlike incumbents, new biotech and pharma companies often lack established sales forces. They launch with a 'digital first' go-to-market strategy, turning to platforms like Doximity early in their lifecycle. This creates a new and rapidly growing customer segment for Doximity, independent of the incumbents' slower transition.

Doximity integrates multiple workflow tools like telehealth and e-signatures. While specialized competitors might offer better individual products, Doximity wins by providing a convenient, all-in-one platform that doctors are already engaged with daily, creating a powerful defensive moat.

Frame marketing strategy not as managing channels, but as "day-trading attention." Identify platforms where user attention is high but advertising costs are low due to a lack of saturation from major brands. This arbitrage opportunity allows smaller players to achieve outsized results before the market corrects.